Par to Begin Shipping Clonidine TDS in the Near Future WOODCLIFF LAKE, N.J., Aug. 18 (HSMN NewsFeed) — Par Laboratory Companies, Inc. (NYSE: PRX ) today announced that its licensing partner, Aveva Drug Delivery Systems, has received final approva…
Biopharmaceuticals, Generics, FDA
Par Medical, Aveva Drug Delivery Systems, clonidine transdermal system

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Par Pharmaceutical and Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)”
Leave a Comment